AAG
TNDM icon

Accordant Advisory Group’s Tandem Diabetes Care TNDM Stock Holding History

Accordant Advisory Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182 Hold
12
– – ﹤0.01% 240
2026
Q1 		$231 Buy
+12
New +$261 ﹤0.01% 236

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Accordant Advisory Group's TNDM Position: Q2 2026 in Review

Accordant Advisory Group held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 12 shares worth $182. The position accounts for ﹤0.01% of the portfolio, ranked #240.

Accordant Advisory Group first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $231 in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Accordant Advisory Group held 12 shares of Tandem Diabetes Care worth $182 as of Q2 2026.
  • Accordant Advisory Group left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Accordant Advisory Group's portfolio in Q2 2026, its #240 holding.
  • Accordant Advisory Group first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
  • Accordant Advisory Group's Tandem Diabetes Care position peaked at $231 in Q1 2026.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Accordant Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.